AMRI Receives CMO Leadership Awards for Excellence

ALBANY, N.Y., March 22, 2017 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a global contract research, development and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and quality of life for more than 25 years, has been recognized for its excellence as a contract manufacturing organization (CMO). AMRI  has been honored as part of the Life Science Leader's 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability.

"Competing with more than 80 contract manufacturers, AMRI is honored to be recognized by our customers from industry pharma and biopharma companies," said William S. Marth, president and CEO, AMRI. "We have made several acquisitions that have increased our strength and scale, invested in our core legacy businesses and have grown to more than 3,000 employees globally. This growth, coupled with expanded services – including extractables and leachables, sterile APIs and pre-filled syringes – solidly positions us to continue to deliver development and manufacturing services, regardless of project size and complexity."

The CMO Leadership Awards are presented annually by Life Science Leader, with winners chosen based on research conducted by Industry Standard Research. The CMO Leadership Awards ensure that quality ratings come from companies that have worked with the CMO within the last 18 months and that results are backed by experiential data.CMOs were eligible to win recognition from up to three groups of respondents: big pharma, small pharma and overall (combined big and small pharma). AMRI earned recognition from all three groups.

"Each year, the CMO Leadership Awards recognize the success that individual drug development and manufacturing organizations have in serving the needs of their biotechnology and pharmaceutical customers and partners," said Louis Garguilo, executive editor of Life Science Leader magazine and OutsourcedPharma.com. "An award in any of the categories adds to the distinction and reputation of CMOs within the greater drug discovery, development, manufacturing and marketing industries."

To learn more about AMRI's capabilities, visit amriglobal.com.

About AMRI
AMRI is a global contract research and manufacturing organization that has been working with the life sciences industry to improve patient outcomes and the quality of life for more than two decades. With locations in North America, Europe and Asia, our key business segments include Discovery and Development Services (DDS), Active Pharmaceutical Ingredients (API), Drug Product (DP), and Fine Chemicals. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).

SOURCE AMRI